Home › Calculator › ERFSF Dividend Calculator 2026
ERFSF DRIP Calculator & Dividend Yield 2026
0.88% YieldHealthcareEurofins Scientific SE · OTC
Price: $96.08 · Annual div: $0.8420/share · Frequency: annual · Payout ratio: 33% · Ex-div: 2026-04-29
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ERFSF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
ERFSF Dividend History — Last 18 Payments
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-04-29Latest | 2026-04-30 | $0.8420 | 1.10% | $76.37 |
| 2025-04-29 | 2025-04-30 | $0.6838 | 2.25% | $54.21 |
| 2024-07-03 | 2024-07-05 | $0.5370 | 1.10% | $48.79 |
| 2023-07-03 | 2023-07-06 | $1.0918 | 3.31% | $64.56 |
| 2022-07-05 | 2022-07-07 | $1.0420 | 1.30% | $80.16 |
| 2021-07-01 | 2021-07-05 | $0.8070 | 0.69% | $117.25 |
| 2019-07-03 | 2019-07-05 | $0.3247 | — | — |
| 2018-06-28 | 2018-07-02 | $0.2773 | — | — |
| 2017-06-29 | 2017-07-03 | $0.2276 | — | — |
| 2016-06-29 | 2016-07-01 | $0.1604 | — | — |
| 2015-06-29 | 2015-07-01 | $0.1474 | — | — |
| 2014-06-27 | 2014-07-02 | $0.1633 | — | — |
| 2013-07-05 | 2013-07-10 | $0.1283 | — | — |
| 2012-04-03 | 2012-04-10 | $0.1067 | — | — |
| 2011-06-14 | 2011-06-17 | $0.2000 | — | — |
| 2010-07-08 | 2010-07-13 | $0.1000 | — | — |
| 2009-06-29 | 2009-07-02 | $0.0141 | — | — |
| 2008-07-21 | 2008-07-24 | $0.0159 | — | — |
About Eurofins Scientific SE (ERFSF) — Dividend Analysis 2026
Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, trackability, and cleanliness. Its offerings span numerous sectors. These include agro-science, encompassing biological evaluations, consumer, human, and environmental safety assessments, product chemical analysis, regulatory guidance, and seed services. The company also handles general agro testing. Its assurance division provides product inspections, audits, certifications, training, and advisory services for items across food, consumer goods, healthcare, and cosmetics industries. Other specialized areas are biopharma and clinical diagnostics. Furthermore, Eurofins conducts comprehensive consumer product testing, covering compliance, audits, examinations, certifications, inspections, training programs, and digital media and cybersecurity solutions for a diverse range of sectors. It also specializes in cosmetics and personal care product analysis, and environmental testing for substances like water, air, soil, waste, and other materials. Food and feed testing is another key segment, addressing concerns such as allergens, GMOs, grain quality, meat composition, nanomaterials, pesticides, and residual DNA. The company's extensive food-related portfolio also includes audit and certification services, authenticity verification, carbohydrate analysis, consulting, detection of dioxins and persistent organic pollutants (POPs), food irradiation checks, labeling compliance, legal guidance, heavy metal screening, identity preservation, mealtime analysis, molecular and microbiology testing, mycotoxin detection, nutritional profiling, organic contaminant analysis, packaging and migration studies, radioactivity testing, rapid testing methods, sensory and consumer research, various training initiatives, veterinary drug residue screening, and vitamin content analysis. Beyond these, Eurofins offers expertise in forensic science, genomics, maritime applications, materials and engineering, REACH compliance, and advanced technologies. The company maintains a significant global presence, operating roughly 900 laboratories across 54 nations. Established in 1987, its main office is situated in Luxembourg City, Luxembourg.
Similar dividend stocks to ERFSF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ERFSF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ERFSF position with:
🌍 ERFSF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ERFSF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.88% | -1.92% | $88 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.75% | -2.05% | $75 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.70% | -2.10% | $70 / yr |
| 🇬🇧 UK ISA | 0% | 0.88% | -1.92% | $88 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.80% | -2.00% | $80 / yr |
| 🇨🇦 TFSA | 0% | 0.88% | -1.92% | $88 / yr |
| 🇨🇦 CA Taxable | 25% | 0.66% | -2.14% | $66 / yr |
| 🇦🇺 Super (pension) | 15% | 0.75% | -2.05% | $75 / yr |
| 🇦🇺 AU Taxable | 30% | 0.62% | -2.18% | $62 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.65% | -2.15% | $65 / yr |
| 🇫🇷 FR Taxable | 30% | 0.62% | -2.18% | $62 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ERFSF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.84/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ERFSF Dividend Payment Schedule
ERFSF pays annually — 1 payment per year.
📊 ERFSF vs Healthcare Benchmarks
How ERFSF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ERFSF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ERFSF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare ERFSF with peers: ERFSF vs BDUUY · ERFSF vs BIOVF · ERFSF vs BMXMF
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ERFSF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Eurofins Scientific SE (ERFSF) is currently trading at $96.08, trading near its 52-week high. The current dividend yield is 0.88% based on an annual payout of $0.8420 per share.
ERFSF (Eurofins Scientific SE) — 0.88% Dividend Yield Analysis
Eurofins Scientific SE (ERFSF) is a healthcare stock currently trading at $96.08 with a dividend yield of 0.88%. It pays an annual dividend of $0.8420 per share. The payout ratio of 33% suggests the dividend is well-covered by earnings. Over the past 5 years, ERFSF has grown its dividend at a compound annual rate of 25.7%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest ERFSF News
LiveHow investors use the ERFSF dividend calculator
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.